✦ LIBER ✦

9075 Phase I study of the combination of docetaxel (D) and pemetrexed (P) in patients with advanced unresectable or metastatic non small cell lung cancer (NSCLC)

✍ Scribed by Kotsakis, A.; Agelaki, S.; Vardakis, N.; Vamvakas, L.; Kalykaki, A.; Kentepozidis, N.; Kontopodis, E.; Sfakiotaki, G.; Mavroudis, D.; Georgoulias, V.

Book ID: 123226287
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 47 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71788-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

223 Docetaxel in combination with vinore

223 Docetaxel in combination with vinorelbine in chemotherapy naive patients with metastatic or unresectable non-small cell lung cancer (NSCLC): Preliminary results of a phase I study

✍ Douillard, J.Y.; Monnier, A.; Le Chevalier, T.; Aapro, M.; Nahon, S.; Sun, X.S.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB

209 Phase I study of docetaxel (D) (Taxo

209 Phase I study of docetaxel (D) (Taxotere®) in combination with ifosfamide (I) in metastatic non small cell lung cancer (NSCLC)

✍ Manegold, Chr.; Buchholz, E.; Schwalb, M.; Achterrath, W.; Drings, P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Pemetrexed combined with paclitaxel in p

Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial

✍ STATHOPOULOS, G; DIMITROULIS, J; TOUBIS, M; KATIS, C; KARAINDROS, D; STATHOPOULO 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 172 KB

P-207 Docetaxel and irinotecan as first

P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II study

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Phase II study of docetaxel and cisplati

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

A phase I trial of the combination taxot

A phase I trial of the combination taxotere® (docetaxel) and cisplatin in patients with advanced non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB